Apr 24 |
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
|
Apr 23 |
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
|
Apr 22 |
Geopolitical Relief Triggers Gold Selloff: Prices Dip Below $2,350 Mark, Mining Stocks Hit Hard
|
Apr 22 |
10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know
|
Apr 18 |
Bruker to acquire Nanostring for $393M
|
Apr 10 |
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
|
Apr 5 |
Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade
|
Mar 26 |
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
|
Mar 21 |
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
|
Mar 13 |
10x Genomics begins shipping Chromium GEM-X products
|